Fennec Pharmaceuticals (RV41.F) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.2
-0.01
0.19
0.38

Details

Expected EPS
-0.0842117331486
Actual EPS
-0.1992277202328
Surprise EPS
-0.12
Surprise Percent
+136.58%

Description

Fennec Pharmaceuticals (RV41.F) has reported earnings of -0.1992277202328 per share for Q4 2024.

0 Comments

Share your thoughts